Cargando…

Long-term adherence to clinical therapy of overactive bladder

Detalles Bibliográficos
Autor principal:	Drake, Marcus John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503977/ https://www.ncbi.nlm.nih.gov/pubmed/28725607 http://dx.doi.org/10.21037/tau.2017.04.13

Ejemplares similares

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Drugs for the overactive bladder: are there differences in persistence and compliance?
por: Andersson, Karl-Erik
Publicado: (2017)

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors
por: Kosilov, Kirill Vladimirovich, et al.
Publicado: (2017)

Update on the management of overactive bladder: patient considerations and adherence
por: Gomelsky, Alex, et al.
Publicado: (2010)

Overactive bladder: strategies to ensure treatment compliance and adherence
por: Dhaliwal, Prabhpreet, et al.
Publicado: (2016)

The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms
por: Housami, Fadi, et al.
Publicado: (2009)

Future directions in overactive bladder treatment: Personalized medicine can be applied?
por: Lee, Kyu-Sung
Publicado: (2015)

Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives
por: Robinson, Dudley, et al.
Publicado: (2023)

A watershed paper for surgical cure of overactive bladder and nocturia
por: Petros, Peter
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Overactive Bladder Disease: The Urge for Better Therapies
por: Thomas, Lisa, et al.
Publicado: (2008)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
por: Sharaf, Ala’a, et al.
Publicado: (2017)

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Drug therapy of overactive bladder - What is coming next?
por: Andersson, Karl-Erik
Publicado: (2015)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Initial clinical experience with selective bladder denervation for refractory overactive bladder
por: Tu, Le Mai, et al.
Publicado: (2018)

Implantable Bladder Sensors for Long-term Monitoring of Bladder Volume
por: Kim, Su Jin
Publicado: (2015)

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
por: Athanasopoulos, Anastasios, et al.
Publicado: (2011)

Overactive bladder, differential diagnosis, and clinical utility of fesoterodine
por: Wyndaele, Jean-Jacques
Publicado: (2012)

Clinical Correlation Between Overactive Bladder and Allergy in Children
por: Yin, Lu, et al.
Publicado: (2022)

Long-term safety, efficacy, and tolerability of imidafenacin in the treatment of overactive bladder: a review of the Japanese literature
por: Masumori, Naoya
Publicado: (2013)

Third‐line therapy for overactive bladder in the elderly: Nuances and considerations
por: Zillioux, Jacqueline, et al.
Publicado: (2022)

Associations among Physician–Patient Communication, Patient Satisfaction, and Clinical Effectiveness of Overactive Bladder Medication: A Survey of Patients with Overactive Bladder
por: Izumi, Naoko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jita4k7radl8m26jvi9dal9d3i